title: Neuropeptide Y- and vasoactive intestinal polypeptide-like immunoreactivity in adjuvant arthritis: effects of capsaicin treatment.
abstract: The occurrence of the neuropeptides vasoactive intestinal polypeptide (VIP) and neuropeptide Y (NPY) in ankle joints and dorsal root ganglia (L2-L6) was analyzed in normal and arthritic Lewis rats. In addition the effect of capsaicin pretreatment was investigated. The study included 92 rats consisting of 4 groups, 23 rats in each; normal rats, normal rats given capsaicin, arthritic rats and arthritic rats pretreated with capsaicin. The localization of the neuropeptides was assessed by immunohistochemistry and the tissue concentrations were determined by radioimmunoassay (RIA). In the arthritic rats, there was a slight increase in NPY immunoreactive nerve fibres in the ankle joint synovium and bone marrow, as compared to normal rats. Notably, there was an intense fluorescence and significant increase (p < 0.01, 41%) in the number of NPY-positive megakaryocytes in the tibial bone marrow of arthritic rats. RIA showed that the concentration of NPY-like immunoreactivity (LI) was increased by 50% in the ankle joint. Pretreatment with capsaicin did not affect the increased level of NPY-LI in the ankle joint of arthritic rats. The concentration of NPY-LI in the dorsal root ganglia was not altered in arthritic rats, nor was it affected by the capsaicin treatment. No NPY immunoreactive cells could be detected in the dorsal root ganglia. The number of VIP immunoreactive nerve fibres observed in ankle joints of arthritic and normal rats did not differ. However, RIA measurements showed an 11% increase in the VIP concentration in arthritic rats, which was unaffected by capsaicin treatment. In dorsal root ganglia, RIA disclosed a 21% increase in VIP-LI, although no VIP-positive cells could be detected. Capsaicin treatment did not affect the increased concentration of VIP-LI in the dorsal root ganglia.
authors.affiliation: Department of Orthopaedics, Karolinska Hospital, Stockholm, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Ahmed
authors.forename: A
authors.initials: A
authors.lastname: Bjurholm
authors.forename: E
authors.initials: E
authors.lastname: Theodorsson
authors.forename: M
authors.initials: M
authors.lastname: Schultzberg
authors.forename: A
authors.initials: A
authors.lastname: Kreicbergs
mesh_terms: D000818:Animals; D001169:Arthritis, Experimental / Q000188:drug therapy* / Q000378:metabolism; D001341:Autonomic Nervous System / Q000378:metabolism; D002211:Capsaicin / Q000627:therapeutic use*; D005260:Female; D007150:Immunohistochemistry; D009478:Neuropeptide Y / Q000032:analysis*; D011863:Radioimmunoassay; D051381:Rats; D011917:Rats, Inbred Lew; D011984:Sensory Receptor Cells / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000032:analysis*
chemical_list: D009478:Neuropeptide Y; D014660:Vasoactive Intestinal Peptide; D002211:Capsaicin